We have located links that may give you full text access.
In vitro and In vivo Activity of Myrsine africana on Elastase Inhibition and Anti-wrinkle Activity.
Pharmacognosy Magazine 2017 October
Background: Myrsine africana (MA) is a plant traditionally used in South Africa to treat various diseases.
Objective: The ethanolic extract of MA, was used for in vitro and in vivo studies to determine its elastase inhibitory activity.
Materials and Methods: MA and its isolated compound, myrsinoside B, were tested in vitro for their elastase inhibitory activity. The MA extract was also evaluated for mutagenicity using two strains of Salmonella typhimurium (TA 98 and TA 100), microbial count, metal analysis, and stability. In vivo studies included irritancy and wrinkle reduction trials using Visioscan and Visioface.
Results: The leaf extract showed good elastase inhibition with a 50% inhibitory concentration (IC50 ) of 28.04 μg/ml. Myrsinoside B inhibited the elastase enzyme at an IC50 of 4.68 ± 0.34 μg/ml. No colony growth observed during mutagenicity studies and it was concluded that MA ethanolic extract is a nonmutagen. MA extract was found to be a nonirritant during the patch test clinical trial. MA was found to contain negligible amounts of microorganisms and heavy metals. Gel cream containing MA crude extract was found to be stable for 2 years when kept at temperatures below 30°C. In clinical trials ( in vivo ), it was found that the test product containing 5% ethanolic extract of MA was effective in reducing wrinkles after application 2 times a day for 14 days and 28 days compared to the placebo aqueous cream.
Conclusion: MA is effective in reducing the appearance of wrinkles.
SUMMARY: This is a first time report of the elastase inhibitory potential of Myrsine africana and myrsinoside B and the anti-wrinkle potential of Myrsine africana Myrsine africana ethanolic extract effectively inhibited the elastase enzyme Myrsine africana was effective in in vivo studies to reduce the appearance of wrinkles after 14 days. Abbreviations used: 4-NQO: 4-nitroquinoline, D14-BL: Baseline to day fourteen, D28-BL: Baseline to day twenty-eight, CFU: Colony forming units, IC50 : 50% inhibitory concentration, MA: Myrsine africana , MOU: Measurement of uncertainty, NaCl: Sodium chloride, NaH2 PO4 .H2 O: Sodium phosphate monobasic monohydrate, SEM: Standard error of the mean, TA 98: Salmonella typhimurium strain 98, TA 100: S. typhimurium strain 100, TLC: Thin layer chromatography, TMA: Total microbial activity, XVB salt: Vogel-Bonner medium E.
Objective: The ethanolic extract of MA, was used for in vitro and in vivo studies to determine its elastase inhibitory activity.
Materials and Methods: MA and its isolated compound, myrsinoside B, were tested in vitro for their elastase inhibitory activity. The MA extract was also evaluated for mutagenicity using two strains of Salmonella typhimurium (TA 98 and TA 100), microbial count, metal analysis, and stability. In vivo studies included irritancy and wrinkle reduction trials using Visioscan and Visioface.
Results: The leaf extract showed good elastase inhibition with a 50% inhibitory concentration (IC50 ) of 28.04 μg/ml. Myrsinoside B inhibited the elastase enzyme at an IC50 of 4.68 ± 0.34 μg/ml. No colony growth observed during mutagenicity studies and it was concluded that MA ethanolic extract is a nonmutagen. MA extract was found to be a nonirritant during the patch test clinical trial. MA was found to contain negligible amounts of microorganisms and heavy metals. Gel cream containing MA crude extract was found to be stable for 2 years when kept at temperatures below 30°C. In clinical trials ( in vivo ), it was found that the test product containing 5% ethanolic extract of MA was effective in reducing wrinkles after application 2 times a day for 14 days and 28 days compared to the placebo aqueous cream.
Conclusion: MA is effective in reducing the appearance of wrinkles.
SUMMARY: This is a first time report of the elastase inhibitory potential of Myrsine africana and myrsinoside B and the anti-wrinkle potential of Myrsine africana Myrsine africana ethanolic extract effectively inhibited the elastase enzyme Myrsine africana was effective in in vivo studies to reduce the appearance of wrinkles after 14 days. Abbreviations used: 4-NQO: 4-nitroquinoline, D14-BL: Baseline to day fourteen, D28-BL: Baseline to day twenty-eight, CFU: Colony forming units, IC50 : 50% inhibitory concentration, MA: Myrsine africana , MOU: Measurement of uncertainty, NaCl: Sodium chloride, NaH2 PO4 .H2 O: Sodium phosphate monobasic monohydrate, SEM: Standard error of the mean, TA 98: Salmonella typhimurium strain 98, TA 100: S. typhimurium strain 100, TLC: Thin layer chromatography, TMA: Total microbial activity, XVB salt: Vogel-Bonner medium E.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app